| James Henry Bowman Iii, DPM | |
|
401 West 3rd Street, Sylacauga, AL 35150 | |
| (205) 933-9595 | |
| (205) 933-5250 |
| Full Name | James Henry Bowman Iii |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 34 Years |
| Location | 401 West 3rd Street, Sylacauga, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245228667 | NPI | - | NPPES |
| 515-91734 | Other | AL | ST. VINCENT'S HOSPITAL (BLUE CROSS LOC NUMBER) |
| 515-49895 | Other | AL | COOSA VALLEY MEDICAL CENTER (BLUE CROSS LOC.NUMBER) |
| 515-49622 | Other | AL | BIRMINGHAM OUTPT SURGERY CENTER (BLUE CROSS LOC.NUMBER) |
| C08447018 | Other | AL | EMDEON SUBMITTER ID |
| 968248 | Other | AL | UNITED HEALTHCARE |
| 515-93484 | Other | AL | SYLACAUGA HEALTH CARE & REHAB (SNF) (BC LOC. NUMBER) |
| 697685 | Other | AL | UHC GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 0124 (Alabama) | Secondary |
| 213ES0131X | Podiatrist - Foot Surgery | 0124 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coosa Valley Medical Center | Sylacauga, AL | Hospital |
| St Vincent's Birmingham | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Podiatry Associates Pc | 0749200442 | 4 |
News Archive
Tackling the scar tissue that shields pancreatic tumors from effective drug access is a promising advance in a notoriously hard-to-treat cancer.
Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.
Alpha Systems, a premier provider of electronic data and document management solutions, today announced that Butler Health System (Butler), an innovative healthcare provider located in Pennsylvania, has named Alpha Systems their vendor of choice for enterprise electronic document management (EDM) software. This move is designed to improve Butler's communication across the enterprise while moving the healthcare provider closer to a paperless environment.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
A study funded by the National Institutes of Health (NIH) has transformed scientists' understanding of Rett syndrome, a genetic disorder that causes autistic behavior and other disabling symptoms. Until now, scientists thought that the gene behind Rett syndrome was an "off" switch, or repressor, for other genes. But the new study, published today in Science, shows that it is an "on" switch for a startlingly large number of genes.
› Verified 8 days ago
| Provider Name | Podiatry Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497957500 PECOS PAC ID: 0749200442 Enrollment ID: O20051123000644 |
News Archive
Tackling the scar tissue that shields pancreatic tumors from effective drug access is a promising advance in a notoriously hard-to-treat cancer.
Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.
Alpha Systems, a premier provider of electronic data and document management solutions, today announced that Butler Health System (Butler), an innovative healthcare provider located in Pennsylvania, has named Alpha Systems their vendor of choice for enterprise electronic document management (EDM) software. This move is designed to improve Butler's communication across the enterprise while moving the healthcare provider closer to a paperless environment.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
A study funded by the National Institutes of Health (NIH) has transformed scientists' understanding of Rett syndrome, a genetic disorder that causes autistic behavior and other disabling symptoms. Until now, scientists thought that the gene behind Rett syndrome was an "off" switch, or repressor, for other genes. But the new study, published today in Science, shows that it is an "on" switch for a startlingly large number of genes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Henry Bowman Iii, DPM 1717 11th Ave S, Suite 402, Birmingham, AL 35205-4731 Ph: (205) 933-9595 | James Henry Bowman Iii, DPM 401 West 3rd Street, Sylacauga, AL 35150 Ph: (205) 933-9595 |
News Archive
Tackling the scar tissue that shields pancreatic tumors from effective drug access is a promising advance in a notoriously hard-to-treat cancer.
Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.
Alpha Systems, a premier provider of electronic data and document management solutions, today announced that Butler Health System (Butler), an innovative healthcare provider located in Pennsylvania, has named Alpha Systems their vendor of choice for enterprise electronic document management (EDM) software. This move is designed to improve Butler's communication across the enterprise while moving the healthcare provider closer to a paperless environment.
Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.
A study funded by the National Institutes of Health (NIH) has transformed scientists' understanding of Rett syndrome, a genetic disorder that causes autistic behavior and other disabling symptoms. Until now, scientists thought that the gene behind Rett syndrome was an "off" switch, or repressor, for other genes. But the new study, published today in Science, shows that it is an "on" switch for a startlingly large number of genes.
› Verified 8 days ago
Podiatry Associates Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 401 West 3rd Street, Sylacauga, AL 35150 Phone: 256-249-2212 Fax: 205-933-5250 |